S&P 500 7,623.68 −0.52%
Nasdaq 25,955.34 −0.21%
S&P/TSX 35,788.18 −0.52%
Apple 347.73 −0.14%
Nvidia 210.96 −0.59%
Microsoft 524.51 +0.66%
Shopify 236.24 −0.07%
Royal Bank 281.77 −0.36%
CAD/USD 0.7141 −0.01%
CLOSED · 03:25 ET
Market ClerkRecap
Sat Oct 24 · markets closed6 signals on Oct 2394 insider buys this week · $48.3MCIRO short report next: Oct 30The week ahead
KJ
INSIDER · INBX · Inhibrx Biosciences, Inc. · DIRECTOR

Kayyem Jon Faiz

Every open-market transaction filed under this name, Sep 8 to Sep 23.

Filings
3
3 buys · 0 sells
Bought
$1.6M
open market, at cost
Sold
—
includes scheduled sales
Buys since
−8.5%
avg move from buy price, 3 priced

Filings

SEC FORM 4 · OPEN MARKET
TradedTickerCompanyRoleTypeSharesPriceValueSince
Sep 23INBXInhibrx Biosciences, Inc.DirectorBuy5,000$100.00$500K−4.7%
Sep 16INBXInhibrx Biosciences, Inc.DirectorBuy5,000$100.00$500K−4.7%
Sep 8INBXInhibrx Biosciences, Inc.DirectorBuy5,000$113.52$568K−16.0%

"Since" is the stock's move from the filed price to the latest quote on file, not a scored call. Open-market purchases and sales only; option exercises and grants are excluded.